Answers are grounded in this paper and cite their sources.
Objective: The objective of the study is to investigate the impact of maternal metabolic syndrome parameters and lipid profiles on fetal growth in pregnancies with gestational diabetes and with normal glucose tolerance.The second aim was to compare the metabolic profiles of pregnant women with gestational diabetes mellitus and with normal glucose tolerance.Material and Methods: Pregnant women who applied for an oral glucose tolerance test were recruited and followed up prospectively.They were also examined for metabolic syndrome, including serum lipid profile between 24 th and 28 th weeks.The group diagnosed with gestational diabetes and those with normal glucose tolerance were compared in terms of obesity, hypertension, serum lipid profile, and neonatal birth weight.Hypertriglyceridemic and normotriglyceridemic patients were compared regarding maternal metabolic syndrome criteria and neonatal birthweight.Results: Diabetic pregnant women had significantly higher body mass index (BMI) and triglyceride levels and lower high-density lipoprotein (LP) levels than non-diabetics.The hypertension rate was also higher; however, it was not statistically significant.Those with hypertriglyceridemia had higher BMI, hemoglobin (HbA1c) level, and neonatal birth weight in the diabetic group, whereas triglyceride level did not impact neonatal birthweight in non-diabetic patients.Obesity, high HbA1c, and triglyceride levels, and low high-density LP levels were the parameters leading to fetal macrosomia in gestational diabetes.Conclusion: Increased accumulation of glucose toward the fetus is not the only mechanism of macrosomia.Parameters of metabolic syndrome affect fetal growth concomitantly.Diabetic women should be evaluated in the context of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Lütfiye Uygur (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: